HMPL-760 in Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

Clinical trial NCT05190068 · COMPLETED

Trial details

NCT number: NCT05190068
Sponsor: Hutchmed
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

B-Cell Non-Hodgkin's Lymphoma

Start date: 2022-01-04
Primary completion: 2025-01-27
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.